Preparation and ocular pharmacokinetics of hyaluronan acid-modified mucoadhesive liposomes

Reference

• Aksungur P, Demirbilek M, Denkbaş EB, et al. (2011). Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies. J Control Release 151:286–94
   PubMed Web of Science ®Google Scholar
• Baba K, Tanaka Y, Kubota A, et al. (2011). A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye. J Control Release 153:278–87
   PubMed Web of Science ®Google Scholar
• Boncler M, Różalski M, Krajewska U, et al. (2014). Comparison of PrestoBlue and MTT assays of cellular viability in the assessment of anti-proliferative effects of plant extracts on human endothelial cells. J Pharmacol Toxicol Methods 69:9–16
   PubMed Web of Science ®Google Scholar
• Cao F, Wang Y, Ping Q, Liao Z. (2011). Zn-Al-NO(3)-layered double hydroxides with intercalated diclofenac for ocular delivery. Int J Pharm 404:250–6
   PubMed Web of Science ®Google Scholar
• Cheng L, Hostetler KY, Chaidhawangul S, et al. (2000). Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation. IOVS 41:1523–32
   PubMed Web of Science ®Google Scholar
• Choi KY, Lee S, Park K, et al. (2008). Preparation and characterization of hyaluronic acid-based hydrogel nanoparticles. J Phys Chem Solids 69:1591–5
   Web of Science ®Google Scholar
• Das S, Suresh PK, Desmukh R. (2010). Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine 6:318–23
   PubMed Web of Science ®Google Scholar
• Ebrahim S, Peyman GA, Lee APJ. (2005). Applications of liposomes in ophthalmology. Surv Ophthalmol 50:167–82
   PubMed Web of Science ®Google Scholar
• Fetterly GJ, Aras U, Murphy DL, et al. (2013). Development of a preclinical PK/PD model to assess antitumor response of a sequential aflibercept and doxorubicin-dosing strategy in acute myeloid leukemia. AAPS J 15:662–73
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Miyai H, Hironaka K, et al. (2012). Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes. Int J Pharm 436:564–7
   PubMed Web of Science ®Google Scholar
• Gan L, Wang J, Jiang M, et al. (2013). Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers. Drug Discov Today 18:290–7
   PubMed Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, et al. (2010). Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomed-Nanotechnol 6:324–33
   PubMed Web of Science ®Google Scholar
• Hiscott P, Wong D. (2010). Proliferative vitreoretinopathy. In: Dartt DA, Besharse JC, Dana R, eds. Encyclopedia of the eye. USA: Academic Press, 526–34
   Google Scholar
• Honda M, Asai T, Oku N, et al. (2013). Liposomes and nanotechnology in drug development: focus on ocular targets. Int J Nanomed 8:495–503
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhang Z, Zhang Y, et al. (2012). Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Biomaterials 33:9246–58
   PubMed Web of Science ®Google Scholar
• Kaiser JM, Imai H, Haakenson JK, et al. (2013). Nanoliposomal minocycline for ocular drug delivery. Nanomedicine 9:130–40
   PubMed Web of Science ®Google Scholar
• Kuo HK, Chen YH, Wu PC, et al. (2012). Attenuated glial reaction in experimental proliferative vitreoretinopathy treated with liposomal doxorubicin. Invest Ophthalmol Vis Sci 53:3167–74
   PubMedGoogle Scholar
• Law S, Huang K, Chiang C. (2000). Acyclovir-containing liposomes for potential ocular delivery Corneal penetration and absorption. J Control Release 63:135–45
   PubMed Web of Science ®Google Scholar
• Li N, Zhuang C, Miwanga XS, et al. (2009). Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 379:131–8
   PubMed Web of Science ®Google Scholar
• Li X, Nie S, Kong J, et al. (2008). A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 363:177–82
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Z, Li J, et al. (2012). Diclofenac-biodegradable polymer micelles for ocular applications. Nanoscale 4:4667–73
   PubMed Web of Science ®Google Scholar
• Lin C, Marjan Javadi B, Belnap DM, et al. (2014). Ultrasound sensitive eLiposomes containing doxorubicin for drug targeting therapy. Nanomedicine 10:67–76
   PubMed Web of Science ®Google Scholar
• Liu S, Jones L, Gu FX. (2012). Nanomaterials for ocular drug delivery. Macromol Biosci 12:608–20
   PubMed Web of Science ®Google Scholar
• Llopis MD, Martos MJ, Espana E, et al. (1992). Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients. Doc Ophthalmol 82:297–305
   PubMed Web of Science ®Google Scholar
• Mannermaa E, Vellonen K-S, Urtti A. (2006). Drug transport in corneal epithelium and blood–retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58:1136–63
   PubMed Web of Science ®Google Scholar
• Peyman G, Ganiban G. (1995). Delivery systems for intraocular routes. Adv Drug Deliv Rev 16:107–23
   Web of Science ®Google Scholar
• Sasaki H, Karasawa K, Hironaka K, et al. (2013). Retinal drug delivery using eyedrop preparations of poly-l-lysine-modified liposomes. Eur J Pharm Biopharm 83:364–9
   PubMed Web of Science ®Google Scholar
• Shen J, Wang Y, Ping Q, et al. (2009). Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J Control Release 137:217–23
   PubMed Web of Science ®Google Scholar
• Shen Y, Tu J. (2007). Preparation and ocular pharmacokinetics of ganciclovir liposomes. AAPS J 9:371–7
   PubMed Web of Science ®Google Scholar
• Sunalp M, Wiedemann P, Sorgente N, Ryan S. (1984). Effects of Cyto-toxic drugs on proliferative vitreoretinopathy in the rabbit-cell injection model. Curr Eye Res 3:619–23
   PubMed Web of Science ®Google Scholar
• Sunalpa MA, Wiedemanna P, Sorgentea N, Ryan SJ. (1985). Effect of adriamycin on experimental proliferative vitreoretinopathy in the rabbit. Exp Eye Res 41:105–15
   PubMed Web of Science ®Google Scholar
• Urtti A. (2006). Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev 58:1131–5
   PubMed Web of Science ®Google Scholar
• Volodkin D, Mohwald H, Voegel JC, Ball V. (2007). Coating of negatively charged liposomes by polylysine: drug release study. J Control Release 117:111–20
   PubMed Web of Science ®Google Scholar
• Wu P, Tsai Y, Liao C, et al. (2004). The characterization and biodistribution of cefoxitin-loaded liposomes. Int J Pharm 271:31–9
   PubMed Web of Science ®Google Scholar
• Yenice I, Mocan MC, Palaska E, et al. (2008). Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea. Exp Eye Res 87:162–7
   PubMed Web of Science ®Google Scholar